FMR LLC 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 1:36 pm Sale | 2025-12-31 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,600,920 9.800% | -1,264,137 (-18.41%) | Filing |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 6,865,057 12.500% | -547,925 (-7.39%) | Filing |
| 2025-08-06 12:14 pm Purchase | 2025-06-30 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 7,412,982 13.600% | 1,553,971 (+26.52%) | Filing |
| 2025-06-06 10:03 am Purchase | 2025-05-30 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,859,011 10.700% | 5,854,011 (+117080.22%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 5,000 0.011% | -3,029,649 (-99.84%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 3,034,649 7.696% | 479,850 (+18.78%) | Filing |
| 2022-02-09 10:01 am Sale | 2022-02-08 | 13G | STOKE THERAPEUTICS INC STOK | FMR LLC | 2,554,799 6.944% | -1,046,176 (-29.05%) | Filing |